The complexity of the humoral immune response against HLA antigens

Transplant International

Volumn 27, Issue 3, 2014, Pages 249-250

  Schaub, Stefan ^a   Hönger, Gideon ^a   Amico, Patrizia ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; HLA ANTIGEN;

BLOOD; DONOR; FEMALE; HUMAN; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MALE;

FEMALE; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; TISSUE DONORS;

EID: 84894033203     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12230     Document Type: Note

References (5)

1. Mohan S, Palanisamy A, Tsapepas D, et al,. Donor-specific antibodies adversely affect kidney allograft outcomes. J Am Soc Nephrol 2012; 23: 2061.
2. Wiebe C, Gibson IW, Blydt-Hansen TD, et al,. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant 2012; 12: 1157.
3. Arnold ML, Ntokou IS, Doxiadis II, Spriewald BM, Boletis JN, Iniotaki AG,. Donor specific HLA antibodies: Evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1/IgG3 to non-complement fixing IgG2/IgG4 anti HLA alloantibodies. Transpl Int 2014; 27: 253.
4. Hönger G, Hopfer H, Arnold ML, Spriewald BM, Schaub S, Amico P,. Pretransplant IgG subclasses of donor-specific human leukocyte antigen antibodies and development of antibody-mediated rejection. Transplantation 2011; 92: 41.
5. Lowe D, Higgins R, Zehnder D, Briggs DC,. Significant IgG subclass heterogeneity in HLA-specific antibodies: Implications for pathogenicity, prognosis, and the rejection response. Hum Immunol 2013; 74: 666.